Atieh Hajirahimkhan, PhD
@atiehhajirahimkhan.bsky.social
Research Assistant Professor
Department of Surgery &
the Robert H Lurie Comprehensive Cancer Center, Northwestern University
Scientist, Mom, Arts & Literature Enthusiast
Department of Surgery &
the Robert H Lurie Comprehensive Cancer Center, Northwestern University
Scientist, Mom, Arts & Literature Enthusiast
Published (early view):
Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention - Hajirahimkhan - International Journal of Cancer - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention - Hajirahimkhan - International Journal of Cancer - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention
Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at-risk women. Adverse effects, however, significantly minimize uptake a...
onlinelibrary.wiley.com
December 3, 2025 at 10:44 PM
Published (early view):
Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention - Hajirahimkhan - International Journal of Cancer - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention - Hajirahimkhan - International Journal of Cancer - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...
Had the pleasure of meeting with a highly devoted group of breast cancer survivors/advocates, today.
Several of these phenomenal women have survived multiple relapse episodes or the metatatic disease, thanks to breast cancer research.
#LynnSageBreasCancerSymposium
#susangkomen
Several of these phenomenal women have survived multiple relapse episodes or the metatatic disease, thanks to breast cancer research.
#LynnSageBreasCancerSymposium
#susangkomen
October 23, 2025 at 10:20 AM
Had the pleasure of meeting with a highly devoted group of breast cancer survivors/advocates, today.
Several of these phenomenal women have survived multiple relapse episodes or the metatatic disease, thanks to breast cancer research.
#LynnSageBreasCancerSymposium
#susangkomen
Several of these phenomenal women have survived multiple relapse episodes or the metatatic disease, thanks to breast cancer research.
#LynnSageBreasCancerSymposium
#susangkomen
Had a pleasure of giving an engaging talk on breast cancer awareness and risk reduction @ Kellanova on the "Tech Day of Pink".
#OctoberIsBreastCancerAwarenessMonth
#OctoberIsBreastCancerAwarenessMonth
October 11, 2025 at 4:15 PM
Had a pleasure of giving an engaging talk on breast cancer awareness and risk reduction @ Kellanova on the "Tech Day of Pink".
#OctoberIsBreastCancerAwarenessMonth
#OctoberIsBreastCancerAwarenessMonth
May 18, 2025 at 2:54 PM
I am honored to be recognized as one of the only 9 scientists nationwide to be selected by the Division of Cancer Preventin in NCI as the 2025 DCP Early Career Scientist. As part of this reconition I presented a seminar for the broader NCI community.
prevention.cancer.gov/news-and-eve...
prevention.cancer.gov/news-and-eve...
Meet the 2025 Cohort of the DCP Early Career Scientists
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) is pleased to announce the 2025 cohort of the DCP Early Career Scientist Spotlight
prevention.cancer.gov
April 29, 2025 at 4:57 AM
I am honored to be recognized as one of the only 9 scientists nationwide to be selected by the Division of Cancer Preventin in NCI as the 2025 DCP Early Career Scientist. As part of this reconition I presented a seminar for the broader NCI community.
prevention.cancer.gov/news-and-eve...
prevention.cancer.gov/news-and-eve...
